Oryzon Genomics S.A. (BME:ORY)
2.640
+0.055 (2.13%)
May 15, 2025, 5:35 PM CET
Oryzon Genomics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | - | 5.82 | 13.55 | 22.78 | 32.67 | 48.45 | Upgrade
|
Cash & Short-Term Investments | - | 5.82 | 13.55 | 22.78 | 32.67 | 48.45 | Upgrade
|
Cash Growth | - | -57.06% | -40.53% | -30.26% | -32.57% | 22.46% | Upgrade
|
Other Receivables | - | 3.21 | 2.22 | 4.1 | 4.3 | 3 | Upgrade
|
Receivables | - | 3.21 | 2.22 | 4.1 | 4.3 | 3 | Upgrade
|
Inventory | - | 0 | 0.01 | 0.01 | 0.12 | 0.39 | Upgrade
|
Other Current Assets | - | 0.02 | 0.01 | - | - | 0 | Upgrade
|
Total Current Assets | - | 9.06 | 15.78 | 26.89 | 37.08 | 51.84 | Upgrade
|
Property, Plant & Equipment | - | 0.37 | 0.53 | 0.65 | 0.78 | 0.79 | Upgrade
|
Long-Term Investments | - | - | - | - | - | 0.05 | Upgrade
|
Other Intangible Assets | - | 0.23 | 0.42 | 0.56 | 0.72 | 0.25 | Upgrade
|
Long-Term Deferred Tax Assets | - | 2.47 | 2.46 | 2.19 | 2.06 | 2.21 | Upgrade
|
Long-Term Deferred Charges | - | 100.29 | 98.94 | 80.5 | 67.81 | 59.95 | Upgrade
|
Other Long-Term Assets | - | 0.13 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
Total Assets | - | 112.55 | 118.16 | 110.83 | 108.48 | 115.12 | Upgrade
|
Accounts Payable | - | 2.2 | 3.77 | 5.41 | 3.31 | 2.45 | Upgrade
|
Accrued Expenses | - | 0.6 | 0.66 | 0.58 | 1.41 | 0.75 | Upgrade
|
Short-Term Debt | - | - | - | - | - | 0.17 | Upgrade
|
Current Portion of Long-Term Debt | - | 9.04 | 13.17 | 13.01 | 4.74 | 5.77 | Upgrade
|
Current Portion of Leases | - | 0.02 | 0.02 | 0.02 | - | - | Upgrade
|
Other Current Liabilities | - | 0.28 | 0.51 | 1 | 0.4 | 0.27 | Upgrade
|
Total Current Liabilities | - | 12.15 | 18.14 | 20.02 | 9.86 | 9.41 | Upgrade
|
Long-Term Debt | - | 7.68 | 6.94 | 10.97 | 15.19 | 10.62 | Upgrade
|
Long-Term Leases | - | 0.04 | 0.06 | 0.08 | - | - | Upgrade
|
Long-Term Deferred Tax Liabilities | - | 2.47 | 2.46 | 2.19 | 2.06 | 2.21 | Upgrade
|
Other Long-Term Liabilities | - | - | 0.17 | - | - | - | Upgrade
|
Total Liabilities | - | 22.44 | 27.77 | 33.27 | 27.43 | 22.23 | Upgrade
|
Common Stock | - | 3.41 | 3.38 | 2.97 | 3.02 | 3.25 | Upgrade
|
Additional Paid-In Capital | - | 104.27 | 102.12 | 85.16 | 84.11 | 90.47 | Upgrade
|
Retained Earnings | - | -19.97 | -17.27 | -13.11 | -9.14 | -4.1 | Upgrade
|
Treasury Stock | - | -2.1 | -0.6 | -0.66 | -0.79 | -0.85 | Upgrade
|
Comprehensive Income & Other | - | 4.51 | 2.77 | 3.2 | 3.85 | 4.11 | Upgrade
|
Shareholders' Equity | - | 90.12 | 90.39 | 77.56 | 81.04 | 92.88 | Upgrade
|
Total Liabilities & Equity | - | 112.55 | 118.16 | 110.83 | 108.48 | 115.12 | Upgrade
|
Total Debt | - | 16.79 | 20.2 | 24.09 | 19.92 | 16.56 | Upgrade
|
Net Cash (Debt) | - | -10.97 | -6.65 | -1.31 | 12.74 | 31.89 | Upgrade
|
Net Cash Growth | - | - | - | - | -60.04% | 29.13% | Upgrade
|
Net Cash Per Share | - | -0.17 | -0.11 | -0.02 | 0.24 | 0.60 | Upgrade
|
Filing Date Shares Outstanding | 64.75 | 64.75 | 60.88 | 55.29 | 52.76 | 52.76 | Upgrade
|
Total Common Shares Outstanding | 64.75 | 64.75 | 60.88 | 55.29 | 52.76 | 52.76 | Upgrade
|
Working Capital | - | -3.1 | -2.36 | 6.88 | 27.22 | 42.43 | Upgrade
|
Book Value Per Share | - | 1.39 | 1.48 | 1.40 | 1.54 | 1.76 | Upgrade
|
Tangible Book Value | - | 89.88 | 89.97 | 77 | 80.33 | 92.63 | Upgrade
|
Tangible Book Value Per Share | - | 1.39 | 1.48 | 1.39 | 1.52 | 1.76 | Upgrade
|
Machinery | - | 1.68 | 1.79 | 1.76 | 1.82 | 1.91 | Upgrade
|
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.